相关实验视频
Updated: Jan 15, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.3K
在现实环境中,在1型糖尿病成年人中使用双激素完全闭环系统的用户体验:定性分析
Giesje Nefs1,2,3,4, Theodorus J P Jansen5, Michel Klaassen5
1Department of Medical Psychology, Radboud University Medical Center, Nijmegen, the Netherlands.
Diabetes technology & therapeutics
|October 7, 2025
概括
双荷尔蒙完全闭环 (FCL) 系统可以改善1型糖尿病患者的葡萄糖控制和生活质量. 持续使用取决于应对技术挑战,持续支持对于采用至关重要.
科学领域:
- 内分泌学和新陈代谢学
- 生物医学工程 生物医学工程
- 糖尿病 技术 技术
背景情况:
- 双激素完全闭环 (FCL) 系统,或人工胰腺,使用胰岛素和葡萄糖进行反应性葡萄糖管理.
- 定量研究证实了FCL在小组环境中的有效性,但用户体验仍然不太了解.
研究的目的:
- 定性地探索成人1型糖尿病使用者的动机,经验和对现实世界使用的双激素FCL系统的感知权衡.
- 调查FCL采用的原因,影响 (正面和负面),调整过程和利益负担平衡.
主要方法:
- 从12个月的FREE 1试验中对参与者的子样本 (n=12) 进行定性采访.
- 选择包括持续使用者 (n=8) 和停止使用者 (n=4),基于试验数据和停止使用的原因.
- 面试数据的专题和叙事分析.
主要成果:
- 用户引用了个人和利他主义的理由开始FCL;好处通常超过负担.
- 持续使用者报告说,尽管有技术管理努力,但生活发生了积极的变化;调整需要时间和应对策略.
- 停药与早期的负面经历和累积的麻烦有关.
结论:
- 双激素FCL系统可以改善血糖和个人报告的结果,但长期使用取决于管理与技术相关的负担.
- 有效的期望管理和制造商和医疗保健团队的持续支持对于成功的FCL采用和持续使用至关重要.
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
680
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
680
Diabetes Mellitus: Overview and Type I Subtype
4.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.9K
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Diabetes: Management and Pharmacotherapy
867
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
867
Feedback Loops
64.1K
In most cases, excessive hormone production is prevented by negative feedback—a loop that starts with a stimulus inducing the release of a particular substance, like a hormone, to maintain a certain level before triggering a signal that results in a decrease in further release of the hormone.
64.1K
Diabetes: Symptoms, Diagnosis, and Complications
2.1K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.1K

